Avoiding Frankenstein’s Monster and Partial Analysis Problems: Robustly Synthesising, Translating and Extrapolating Evidence

作者: Simon Eckermann

DOI: 10.1007/978-3-319-50613-5_3

关键词:

摘要: Chapter 2 highlighted how satisfying decision analytic principles of coverage and comparability with joint consideration cost effects are fundamental to allowing unbiased trial-based effectiveness analysis for two-strategy comparisons. In this chapter, we extend these identify methods robust relevant making in any given jurisdiction interest (e.g. Australia a PBAC remit, the UK NICE remit), while highlighting common biases, pitfalls fallacies that should be avoided. Satisfying is shown usually require evidence synthesis translation potentially extrapolation. particular, required which avoid inferential selection biases associated partialisation (O’Brien 1996; Briggs O’Brien 2001) alternative framing binary outcomes (Eckermann Willan 2009, 2011).

参考文章(34)
D. G Altman, J M. Bland, Absence of evidence is not evidence of absence BMJ. ,vol. 311, pp. 485- 485 ,(1995) , 10.1136/BMJ.311.7003.485
Ian C Marschner, David Colquhoun, R John Simes, Paul Glasziou, Philip Harris, Bhuwan B Singh, Denis Friedlander, Harvey White, Peter Thompson, Andrew Tonkin, LIPID Study Investigators, None, Long-term risk stratification for survivors of acute coronary syndromes - Results from the long-term intervention with pravastatin in ischemic disease (LIPID) study Journal of the American College of Cardiology. ,vol. 38, pp. 56- 63 ,(2001) , 10.1016/S0735-1097(01)01360-2
Michael F Drummond, Mark J Sculpher, Karl Claxton, Greg L Stoddart, George W Torrance, Methods for the Economic Evaluation of Health Care Programmes ,(1987)
Joseph L. Fleiss, Measures of effect size for categorical data. Russell Sage Foundation. ,(1994)
SANDER GREENLAND, Interpretation and choice of effect measures in epidemiologic analyses American Journal of Epidemiology. ,vol. 125, pp. 761- 768 ,(1987) , 10.1093/OXFORDJOURNALS.AJE.A114593
Simon D. Eckermann, Andrew J. Martin, Martin R. Stockier, R. John Simes, The benefits and costs of tamoxifen for breast cancer prevention Australian and New Zealand Journal of Public Health. ,vol. 27, pp. 34- 40 ,(2003) , 10.1111/J.1467-842X.2003.TB00377.X
Simon Eckermann, Michael Coory, Andrew R. Willan, Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest PharmacoEconomics. ,vol. 29, pp. 87- 96 ,(2011) , 10.2165/11585910-000000000-00000
S.D Walter, Choice of effect measure for epidemiological data. Journal of Clinical Epidemiology. ,vol. 53, pp. 931- 939 ,(2000) , 10.1016/S0895-4356(00)00210-9
Simon Eckermann, Michael Coory, Andrew R. Willan, Indirect comparison: relative risk fallacies and odds solution Journal of Clinical Epidemiology. ,vol. 62, pp. 1031- 1036 ,(2009) , 10.1016/J.JCLINEPI.2008.10.013